Insider Stock Trading History of Meglasson Martin


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Meglasson Martin since year 2005. The trader's CIK number is 1280564. At the time of this reporting, Meglasson Martin is the Chief Scientific Officer of Bellerophon Therapeutics, Inc. . (stock ticker symbol BLPH). See this page for all insider trading activities at Bellerophon Therapeutics, Inc. .

Note that in the past MEGLASSON MARTIN also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Meglasson Martin since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-05-20 BLPH Bellerophon Therapeutics, Inc. Buy 712 8.40 5,980
2015-02-19 BLPH Bellerophon Therapeutics, Inc. Buy 12,000 12.00 144,000
2010-05-11 LGND Ligand Pharmaceuticals Inc Buy 6,250 1.63 10,187
2008-05-09 LGND Ligand Pharmaceuticals Inc Buy 3,000 3.36 10,077
2007-08-30 LGND Ligand Pharmaceuticals Inc Buy 2,000 6.20 12,390
2006-12-15 LGND Ligand Pharmaceuticals Inc Sale 5,313 11.23 59,654
2006-12-15 LGND Ligand Pharmaceuticals Inc Option Ex 5,313 7.25 38,519

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Meglasson Martin (Chief Scientific Officer of Bellerophon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.